Deutsche Bank’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,400
Closed -$27K 4019
2022
Q2
$27K Sell
2,400
-166,920
-99% -$2M ﹤0.01% 3891
2022
Q1
$2.75M Buy
169,320
+10,777
+7% +$276K ﹤0.01% 1708
2021
Q4
$7.51M Sell
158,543
-1,142
-0.7% -$68.5K ﹤0.01% 1229
2021
Q3
$11.6M Buy
159,685
+12,964
+9% +$937K 0.01% 1094
2021
Q2
$12.3M Buy
+146,721
New +$9.68M 0.01% 1088
2021
Q1
Sell
-200
Closed -$9K 4593
2020
Q4
$9K Buy
200
+98
+96% +$3.86K ﹤0.01% 4305
2020
Q3
$5K Buy
+102
New +$3.36K ﹤0.01% 4250

Other funds holding NBP

Deutsche Bank's NBP Position: Q3 2022 in Review

Deutsche Bank sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 2,400 shares — an estimated $27K sold.

Deutsche Bank first reported a position in NBP in Q3 2020 and held it in 7 quarters. The position peaked at $12.3M in Q2 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Deutsche Bank reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Deutsche Bank sold 2,400 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $27K.
  • Deutsche Bank first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 7 quarters.
  • Deutsche Bank's NovaBridge Biosciences American Depositary Shares position peaked at $12.3M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Deutsche Bank's 13F filing for Q3 2022, filed 14 Nov 2022.